Cancer reduction in mice with Prakasine nanomedicine immunotherapy

References

• Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020 (https://gco.iarc.fr/today., accessed February 2021).
   Google Scholar
• World Health Organization. Cancer; 2020. https://www.who.int/news-room/fact-sheets/detail/cancer#:∼:text.
   Google Scholar
• de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–e190. doi: 10.1016/S2214-109X(19)30488-7.
   PubMed Web of Science ®Google Scholar
• Ren Minghui. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva: World Health Organization; 2020. https://iris.who.int/bitstream/handle/10665/331452/9789240002319-eng.pdf?sequence=1
   Google Scholar
• Key Statistics for Breast Cancer. American Cancer Society; 2023. https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html.
   Google Scholar
• Nounou MI, ElAmrawy F, Ahmed N, et al. Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies. Breast Cancer . 2015; 9(Suppl 2):17–34. PMID: 26462242; PMCID: PMC4589089 doi: 10.4137/BCBCR.S29420.
   PubMedGoogle Scholar
• Ophira Ginsburg MD, Cheng-Har Yip MD, Ari Brooks MM, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126 Suppl 10(Suppl 10):2379–2393. doi: 10.1002/cncr.32887.
   PubMedGoogle Scholar
• Unger-Saldana K, Miranda A, Zarco-Espinosa G, et al. Health system delay and its effect on clinical stage of breast cancer: multicenter study. Cancer. 2015;121(13):2198–2206. doi: 10.1002/cncr.29331.
   PubMed Web of Science ®Google Scholar
• Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–1126. doi: 10.1016/s0140-6736(99)02143-1.
   PubMed Web of Science ®Google Scholar
• Dumitrescu RG, Cotarla I. Understanding breast cancer risk—where do we stand in 2005? J Cell Mol Med. 2005;9(1):208–221. doi: 10.1111/j.1582-4934.2005.tb00350.x.
   PubMed Web of Science ®Google Scholar
• Logan GJ, Dabbs DJ, Lucas PC, et al. Molecular drivers of lobular carcinoma in situ. Breast Cancer Res. 2015;17(1):76. doi: 10.1186/s13058-015-0580-5.
   PubMedGoogle Scholar
• Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493–502. doi: 10.7326/0003-4819-155-8-201110180-00005.
   PubMed Web of Science ®Google Scholar
• O'Connor M, Rhodes D, Hruska C. Molecular breast imaging. Expert Rev Anticancer Ther. 2009;9(8):1073–1080. doi: 10.1586/era.09.75.
   PubMed Web of Science ®Google Scholar
• Palmer ML, Tsangaris TN. Breast biopsy in women 30 years old or less. Am J Surg. 1993;165(6):708–712. doi: 10.1016/s0002-9610(05)80793-7.
   PubMed Web of Science ®Google Scholar
• Kroese M, Zimmern RL, Pinder SE. HER2 status in breast cancer—an example of pharmacogenetic testing. J R Soc Med. 2007;100(7):326–329.
   PubMed Web of Science ®Google Scholar
• Brooks M. Breast cancer screening and biomarkers. Methods Mol Biol. 2009;472:307–321. doi: 10.1007/978-1-60327-492-0_13.
   PubMedGoogle Scholar
• Dhankhar R, Vyas SP, Jain AK, et al. Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol. 2010;38(5):230–249. doi: 10.3109/10731199.2010.494578.
   PubMed Web of Science ®Google Scholar
• Debien V, De Caluwé A, Wang X, et al. Immunotherapy in breast cancer: an overview of current strategies and perspectives. Npj Breast Cancer. 2023;9(1):7. doi: 10.1038/s41523-023-00508-3.
   PubMed Web of Science ®Google Scholar
• Prakash SK. Immunogenic antitumor potential of prakasine nanoparticles in zebrafish by gene expression stimulation. Artif Cells Nanomed Biotechnol. 2023;51(1):41–56. doi: 10.1080/21691401.2023.2173217.
   PubMed Web of Science ®Google Scholar
• Ramyadevi J, Jeyasubramanian K, Marikani A, et al. Copper nanoparticles synthesized by polyol process used to control hematophagous parasites. Parasitol Res. 2011;109(5):1403–1415. doi: 10.1007/s00436-011-2387-3.
   PubMed Web of Science ®Google Scholar
• Kholiya F, Chatterjee S, Bhojani G, et al. Seaweed polysaccharide derived bioaldehyde nanocomposite: Potential application in anticancer therapeutics. Carbohydr Polym. 2020; 240:116282. (https://www.sciencedirect.com/science/article/pii/S0144861720304562). doi: 10.1016/j.carbpol.2020.116282.
   PubMed Web of Science ®Google Scholar
• Tokala R, Sana S, Lakshmi UJ, et al. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity. Bioorg Chem. 2020;105:104357. (https://www.sciencedirect.com/science/article/pii/S0045206820316552). doi: 10.1016/j.bioorg.2020.104357.
   PubMed Web of Science ®Google Scholar
• Kode J, Kovvuri J, Nagaraju B, et al. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorg Chem. 2020; 105:104447–102068. (https://www.sciencedirect.com/science/article/pii/S0045206820317454) (For MTD assay) doi: 10.1016/j.bioorg.2020.104447.
   PubMed Web of Science ®Google Scholar
• Crouch SP, Kozlowski R, Slater KJ, et al. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxcity. J Immunol Methods. 1993;160(1):81–88. doi: 10.1016/0022-1759(93)90011-u.
   PubMed Web of Science ®Google Scholar
• Gonzalez RJ, Tarloff JB. Evaluation of hepatic sub cellular fractions for alamar blue and MTT reductase activity. Toxicol in Vitro. 2001;15(3):257–259. doi: 10.1016/S0887-2333(01)00014-5.
   PubMed Web of Science ®Google Scholar
• Hattori N, Sakakibara T, Kajiyama N, et al. Enhanced microbial biomass assay using mutant luciferase resistant to benzalkonium chloride. Anal Biochem. 2003;319(2):287–295. doi: 10.1016/s0003-2697(03)00322-1.
   PubMed Web of Science ®Google Scholar
• Kangas L, Grönroos M, Nieminen AL, et al. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol. 1984;62(6):338–343.
   PubMedGoogle Scholar
• Lundin A, Hasenson M, Persson J, Pousette A. Estimation of biomass in growing cell lines by adenosine triphosphate assay. Methods Enzymol. 1986;133:27–42. doi: 10.1016/0076-6879(86)33053-2. PMID: 3821540.
   Google Scholar
• Cell viability and proliferation. Mark Frei, BioFiles. 2011; 6(5):17–21.
   Google Scholar
• Denizot FF, Lang RR. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Immunol Meth. 1986;89(2):271–277. doi: 10.1016/0022-1759(86)90368-6.
   Google Scholar
• Kasibhatla S, Amarante-Mendes GP, Finucane D, et al. Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harb Protoc. 2006;2006(3):pdb.prot4493. doi: 10.1101/pdb.prot4493.
   Google Scholar
• Liu K, Liu P-C, Liu R, et al. Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med Sci Monit Basic Res. 2015;21:15–20. doi: 10.12659/MSMBR.893327.
   PubMed Web of Science ®Google Scholar
• Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–1116. doi: 10.1038/nprot.2006.179.
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer drug screening J. J Natl Cancer Inst. 1990;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107.
   PubMed Web of Science ®Google Scholar
• Vigneshwar R, Arivuchelvan A, Mekala P, et al. Sex-specific reference intervals for wistar albino rats: hematology and clinical biochemistry. ijah. 2021;60(1):58–65. doi: 10.36062/ijah.60.1.2021.58-65.
   Google Scholar
• Simona P, Ana-Maria Teodoru NL, Coman C. Hematological and biochemical dynamics of rabbits and guinea pigs used for scientific purposes at Cantacuzino Institute, Bucharest. Rev RomMed Vet. 2021;31, 2:69–80. ISSN:1220-3173; E-ISSN:2457–7618.
   Google Scholar
• Poljičak-Milas N, Kardum-Skelin I, Vuđan M, et al. Blood cell count analyses and erythrocyte morphometry in New Zealand white rabbits. Vet. arhiv. 2009;79(6):561–571.
   Web of Science ®Google Scholar
• Khan SA, Epstein JH, Olival KJ, et al. Hematology and serum chemistry reference values of stray dogs in Bangladesh. Open Vet J. 2011;5(2):13–20. doi: 10.5455/OVJ.2011.v1.i0.p13.
   Google Scholar
• Lumsden JH, Mullen K, McSherry BJ. Canine hematology and biochemistry reference values. Can J Comp Med. 1979;43(2):125–131. PMID: 497885; PMCID: PMC1319907.
   PubMedGoogle Scholar
• Ou W, Stewart S, White A, et al. In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nat Commun. 2023;14(1):392. doi: 10.1038/s41467-023-36045-7.
   PubMedGoogle Scholar
• Sharma P, Wagner K, Wolchok JD, et al. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer. 2011;11(11):805–812. doi: 10.1038/nrc3153.
   PubMed Web of Science ®Google Scholar
• Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651–668. doi: 10.1038/s41577-020-0306-5.
   PubMed Web of Science ®Google Scholar
• Wculek SK, Cueto FJ, Mujal AM, et al. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24. doi: 10.1038/s41577-019-0210-z.
   PubMed Web of Science ®Google Scholar
• Foy, S.P., Jacoby, K., Bota, D.A. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687–696 (2023). doi: 10.1038/s41586-022-05531-1
   Google Scholar
• Hegde PS, Chen DS. Top 10 challenges in cancer immunotherapy. Immunity. 2020;52:17–35. doi: 10.1038/s41586-022-05531-1.
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi: 10.1038/s41591-018-0014-x.
   PubMed Web of Science ®Google Scholar
• Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005;5(4):263–274. doi: 10.1038/nrc1586.
   PubMed Web of Science ®Google Scholar
• Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression—implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16(6):356–371. doi: 10.1038/s41571-019-0175-7.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322. doi: 10.1016/j.ccr.2012.02.022.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Chen J, Zhou H, et al. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy. Nat Commun. 2022;13(1):758. doi: 10.1038/s41467-022-28279-8.
   PubMed Web of Science ®Google Scholar
• Voorwerk L, Isaeva OI, Horlings HM, et al. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. Nat Cancer. 2023;4(4):535–549. doi: 10.1038/s43018-023-00542-x.
   PubMedGoogle Scholar
• Tokumaru Y, Joyce D, Takabe K. Current status and limitations of immunotherapy for breast cancer. Surgery. 2020; ; 167(3):628–630. doi: 10.1016/j.surg.2019.09.018.
   PubMed Web of Science ®Google Scholar
• Panagi M, Mpekris F, Chen P, et al. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Nat Commun. 2022;13(1):7165. doi: 10.1038/s41467-022-34744-1.
   PubMed Web of Science ®Google Scholar
• Schmid P, Adams S, Rugo HS, et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med. 2018;379(22):2108–2121. Article CAS PubMed Google Scholar doi: 10.1056/NEJMoa1809615.
   PubMed Web of Science ®Google Scholar
• Adams S, Diamond JR, Hamilton E, et al. Atezolizumab plus nab-paclitaxel in the treatment of metastatic triple-negative breast cancer with 2-year survival follow-up: a phase 1b clinical trial. JAMA Oncol. 2019;5(3):334–342. Article PubMed Google Scholar doi: 10.1001/jamaoncol.2018.5152.
   PubMed Web of Science ®Google Scholar
• Martin JD, Cabral H, Stylianopoulos T, et al. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17(4):251–266. doi: 10.1038/s41571-019-0308-z.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653–664. doi: 10.1038/nrclinonc.2010.139.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Munn LL, Jain RK. Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside. Trends Cancer. 2018;4(4):292–319. doi: 10.1016/j.trecan.2018.02.005.
   PubMed Web of Science ®Google Scholar
• Martin JD, Seano G, Jain RK. Normalizing function of tumor vessels: progress, opportunities, and challenges. Annu Rev Physiol. 2019;81(1):505–534. doi: 10.1146/annurev-physiol-020518-114700.
   PubMedGoogle Scholar
• Stylianopoulos T, Martin JD, Chauhan VP, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012;109(38):15101–15108. doi: 10.1073/pnas.1213353109.
   PubMed Web of Science ®Google Scholar
• Nia HT, Munn LL, Jain RK. Physical traits of cancer. Science. 2020;370(6516):eaaz0868. doi: 10.1126/science.aaz0868.
   PubMed Web of Science ®Google Scholar
• Voutouri C, Stylianopoulos T. Evolution of osmotic pressure in solid tumors. J Biomech. 2014;47(14):3441–3447. doi: 10.1016/j.jbiomech.2014.09.019.
   PubMed Web of Science ®Google Scholar
• Kalli M, Stylianopoulos T. Defining the role of solid stress and matrix stiffness in cancer cell proliferation and metastasis. Front Oncol. 2018;8:55. doi: 10.3389/fonc.2018.00055.
   PubMed Web of Science ®Google Scholar
• Voutouri C, Stylianopoulos T. Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness. PLOS One. 2018;13(3):e0193801. doi: 10.1371/journal.pone.0193801.
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T, Martin JD, Snuderl M, et al. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013;73(13):3833–3841. doi: 10.1158/0008-5472.CAN-12-4521.
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Boucher Y, Ferrone CR, et al. Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Cancer Cell. 2014;26(1):14–15. doi: 10.1016/j.ccr.2014.06.003.
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324(5933):1457–1461. doi: 10.1126/science.1171362.
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Martin JD, Liu H, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4(1):2516. doi: 10.1038/ncomms.3516.
   PubMedGoogle Scholar
• Sheridan C. Pancreatic cancer provides testbed for first mechanotherapeutics. Nat Biotechnol. 2019;37(8):829–831. Article CAS PubMed Google Scholar doi: 10.1038/d41587-019-00019-2.
   PubMed Web of Science ®Google Scholar
• Martin JD, Miyazaki T, Cabral H. Remodeling tumor microenvironment with nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(6):e1730. doi: 10.1002/wnan.1730.
   PubMed Web of Science ®Google Scholar
• Rasool M, Malik A, Waquar S, et al. New challenges in the use of nanomedicine in cancer therapy. Bioengineered. 2022; 13(1):759–773. PMID: 34856849; PMCID: PMC8805951. doi: 10.1080/21655979.2021.2012907.
   PubMed Web of Science ®Google Scholar
• Prakash SK. Effect of feed supplementation of mercury nanoparticles on immunostimulation of live lentogenic Newcastle disease vaccine in layer birds. Indian Vet J. 2017;94:11–13.
   Google Scholar
• Prakash SK. Immunological and virological effects of novel prakasine nanomedicine in HIV-infected patients in South India: a preliminary study. Virol Antivir Res. 2020;9(2):195.
   Google Scholar
• Prakash SK. Phytochemical therapy as a possible cure for asymptomatic AIDS patients [dissertation]. India: Bharathidasan University; 2010.
   Google Scholar
• Prakash SK. Immunological and virological effects of prakasine nanomedicine in HIV eradication: a preliminary study. Fifth Eastern Europe and Central Asia AIDS conference. ; 2016 23–25. Moscow
   Google Scholar